Papers/PMID:41000008
Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Hypertension (Dallas, Tex. : 1979)2025The record
2 findings drawn from this paper, on 1 compound across 2 endpoints.
What it reported
How to read these marksWhat moved
2 findings
magnesium(2+) — decreases diastolic blood pressure (setting unspecified)
LikelyGrade B, Likely. Human evidence, limited replication or design limits.Findingreplicated ×2“Magnesium intake resulted in a reduction in systolic BP of -2.81 mm Hg (95% CI, -4.32 to -1.29) and diastolic BP by -2.05 mm Hg (95% CI, -3.23 to -0.88) compared with placebo.”
Quoted verbatim from Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Dose
- median 365 mg/d elemental magnesium (range 82.3-637 mg), median intervention period 12 weeks
- Population
- hypertensive and normotensive adults in randomized controlled trials of at least 4 weeks
Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2025PMID:41000008
magnesium(2+) — decreases systolic blood pressure (setting unspecified)
LikelyGrade B, Likely. Human evidence, limited replication or design limits.Findingreplicated ×2“Magnesium intake resulted in a reduction in systolic BP of -2.81 mm Hg (95% CI, -4.32 to -1.29) and diastolic BP by -2.05 mm Hg (95% CI, -3.23 to -0.88) compared with placebo.”
Quoted verbatim from Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Dose
- median 365 mg/d elemental magnesium (range 82.3-637 mg), median intervention period 12 weeks
- Population
- hypertensive and normotensive adults in randomized controlled trials of at least 4 weeks
Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2025PMID:41000008